U.S. Senator Elizabeth Warren increased pressure on regulators to scrutinize CVS Health Corp.‘s $9.5 billion deal to buy Oak Street Health Inc., as part of a broad critique of vertical consolidation in the industry that she says could increase costs and reduce quality.
To read the entire story, you must be logged in.
Please log in now or register with us.
